At the molecular level, mRNAs of TGF‐β1 and TGF‐βR2 were increased at 21 days in BLM treated WT mice as compared to NS treated WT mice, and their expressions were further enhanced in BLM treated IL‐22R−/− mice (Figure 3E–F). This evidence concerns the gene IL22RA1 and Bloom syndrome.